TG Therapeutics: Q3 earnings top expectations
FROM THE WIRE · FINANCE.YAHOO.COM
MORRISVILLE, N.C. (AP) — MORRISVILLE, N.C. (AP) — TG Therapeutics Inc. (TGTX) on Monday reported third-quarter earnings of $55.5 million. On a per-share basis, the Morrisville, North Carolina-based company said it had net income of 35 cents. The results topped Wall Street…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishResults above estimates can support the biopharma stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Q3 net income was $55.5 million, or 35 cents per share.
- 02The average analyst estimate was 28 cents per share.
- 03Revenue reached $259.9 million, above the $247.2 million forecast.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets